A research study published in Cell Reports by a team at Duke University has uncovered a new function of the gene called huntingtin. A mutation in huntingtin underlines the neurodegenerative disorder known as Huntington’s Disease.
A New Look at HuntingtinIn this study, the researchers used a mouse model to study the striatum, a brain region involved in movement. They have discovered that neurons in the striatum require the huntingtin gene in order to regulate movement, maintain cell health and develop connections between cells.
Identifying huntingtin’s role in regulating cellular health and movement may open the door to a new avenue to studying Huntington’s Disease.
We were excited to see our anti-tdTomato listed as a primary antibody used for immunohistochemistry in the study. This antibody recognizes a red fluorescent protein used as a spectrally distinct companion or substitute for green fluorescent protein. It is specifically useful for nontoxic live cell imaging and reporter assays.
This inherited neurodegenerative disorder typically appears in mid-life, leading to impaired motor control, dementia and psychiatric symptoms. Scientists have been aware of the genetic roots of Huntington’s Disease for years; however, there are still no approved treatments to cure or slow the progression of the disease.
The disease is caused when there is a mutation in one of the two copies of the huntingtin gene. This mutation causes the formation of an abnormal version of the huntingtin protein, which is toxic to neurons.
The huntingtin protein is expressed throughout the body, but the striatum is especially susceptible to its damage and begins to degenerate with the progression of the disease. Additionally, the mutant huntingtin can also interfere with the ability of the normal huntingtin protein to function.
Stopping the Mutant Huntingtin
Currently, clinical trials are looking at drugs designed to stop the mutant huntingtin. However, these drugs are also decreasing the amount of normal huntingtin protein. While much was known about huntingtin’s crucial role in cell function, little was known about its specific role in the striatum.
“We hypothesized that the normal huntingtin gene plays a critical role in neuronal health and connectivity, and we wanted to determine what happens to striatal neurons that have had huntingtin eliminated,” said lead author Cagla Eroglu. This hypothesis led to the research published in Cell Reports where the research team deleted the huntingtin gene directly from the striatal neurons of very young mice.
With the huntingtin gene deleted, the neurons began to die as the mice aged, a similar pattern to what is seen in Huntington’s Disease. Further, these mice showed an impaired ability to control movement even before the neurons themselves started to die. This result indicates that cell death itself might not be the sole cause of Huntington’s Disease symptoms.
“We believe changes at the neuronal and synapse level happening before cell death are contributing to the progression of the disease,” said PhD candidate Caley Burrus at the conclusion of the experiment. The team will continue their research by looking at the precise role that huntingtin plays in synapse development. This has the potential to lead to specific drugs designed to target these deficits.
Do you work in this field of research? If so, you may be interested in viewing our other reagents that can be used for neurodegenerative disease research. Some of the reagents include:
- C-DAG Amyloidogenicity Kit from Harvard University
- Anti-Tau [PC1C6 Antibody] from University of Virginia
- Anti-Amyloid Beta Peptide, Pan Specific [MOAB-2] Antibody from University of Illinois at Chicago
- Hyperphosphorylated Microtubule-Associated Protein Tau from Michigan State University
Further, if you were curious about our anti-tdTomato antibody used in the study, we also offer a variety of similar antibodies, including:
- Brainbow Antibodies from University of Michigan
- GFP Antibody from the Scripps Research Institute
- mCherry Antibody (Clone 16D7) from the Scripps Research Institute
- mCherry Antibody (Clone 8C5.5) from University of Massachusetts Medical School